Resources

See how Yseop Copilot is different from other Generative AI technologies across BioPharma and regulated industries.
Reinforcing Yseop’s unique footprint in the GenAI space for BioPharma, a new investment enables Yseop to expand the scope of its Generative AI offerings and accelerate its leadership position in life sciences.
Generative AI technologies enable the pharmaceutical industry to provide enhanced and quality content automation.
Explore the remarkable milestones and moments that shaped Yseop’s journey in life sciences in 2023.
Reinforcing Yseop’s unique footprint in the GenAI space for BioPharma, a new investment enables Yseop to expand the scope of its Generative AI offerings and accelerate its leadership position in life sciences.
Yseop recaps Accenture’s Technology Vision 2023 for Biopharma report.
Listen to the next episode of AI Uncovered with Sarah Tilly.
It’s predicted that generative AI could add as much as $4.4 trillion annually to the global economy. We discuss generative AI and the future of work and why it’s important to embrace its benefits.
The adoption of AI in medical writing has been growing in popularity. In fact, by 2030, the global AI in medical writing market is predicted to reach a value of $1.76 billion.
Scroll to Top